Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163


Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.

Saliba F, Pascher A, Cointault O, Laterre PF, Cervera C, De Waele JJ, Cillo U, Langer RM, Lugano M, Göran-Ericzon B, Phillips S, Tweddle L, Karas A, Brown M, Fischer L; TENPIN (Liver Transplant European Study Into the Prevention of Fungal Infection) Investigators; TENPIN Liver Transplant European Study Into the Prevention of Fungal Infection Investigators.

Clin Infect Dis. 2015 Apr 1;60(7):997-1006. doi: 10.1093/cid/ciu1128. Epub 2014 Dec 17.


Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.

Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1509-16. doi: 10.1016/j.bbmt.2012.03.014. Epub 2012 Mar 30.


Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.

Kubiak DW, Bryar JM, McDonnell AM, Delgado-Flores JO, Mui E, Baden LR, Marty FM.

Clin Ther. 2010 Apr;32(4):637-48. doi: 10.1016/j.clinthera.2010.04.005.


Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.

Sun HY, Cacciarelli TV, Singh N.

Transplantation. 2013 Sep;96(6):573-8. doi: 10.1097/TP.0b013e31829d674f.


Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs.

Wang JF, Xue Y, Zhu XB, Fan H.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):651-9. doi: 10.1007/s10096-014-2287-4. Epub 2014 Dec 14. Review.


Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.

Shang W, Feng G, Sun R, Wang X, Liu W, Zhang S, Li J, Pang X, Wang Y, Zhang W.

J Clin Pharm Ther. 2012 Dec;37(6):652-6. doi: 10.1111/j.1365-2710.2012.01362.x. Epub 2012 Jun 21.


Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.

Neofytos D, Huang YT, Cheng K, Cohen N, Perales MA, Barker J, Giralt S, Jakubowski A, Papanicolaou G.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S652-61. doi: 10.1093/cid/civ818.


Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.

Winston DJ, Limaye AP, Pelletier S, Safdar N, Morris MI, Meneses K, Busuttil RW, Singh N.

Am J Transplant. 2014 Dec;14(12):2758-64. doi: 10.1111/ajt.12963. Epub 2014 Nov 6.


Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.

El-Cheikh J, Venton G, Crocchiolo R, Fürst S, Faucher C, Granata A, Oudin C, Coso D, Bouabdallah R, Vey N, Duran S, Fougereau E, Berger P, Chabannon C, Blaise D.

Bone Marrow Transplant. 2013 Nov;48(11):1472-7. doi: 10.1038/bmt.2013.87. Epub 2013 Jun 10.


Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation.

Hiramatsu Y, Maeda Y, Fujii N, Saito T, Nawa Y, Hara M, Yano T, Asakura S, Sunami K, Tabayashi T, Miyata A, Matsuoka KI, Shinagawa K, Ikeda K, Matsuo K, Tanimoto M; West-Japan Hematology and Oncology Group (West-JHOG).

Int J Hematol. 2008 Dec;88(5):588-595. doi: 10.1007/s12185-008-0196-y. Epub 2008 Nov 29.


Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.

Sohn HS, Lee TJ, Kim J, Kim D.

Clin Ther. 2009 May;31(5):1105-15; discussion 1066-8. doi: 10.1016/j.clinthera.2009.05.011.


Antifungal Prophylaxis in Liver Transplant Recipients.

Winston DJ, Busuttil RW, Singh N.

Clin Infect Dis. 2015 Oct 15;61(8):1349-50. doi: 10.1093/cid/civ565. Epub 2015 Aug 9. No abstract available.


Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.

Maximova N, Schillani G, Simeone R, Maestro A, Zanon D.

Adv Ther. 2017 May;34(5):1184-1199. doi: 10.1007/s12325-017-0534-7. Epub 2017 Apr 20.


Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.

Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang CI, Peck KR, Jung CW.

J Infect. 2016 Nov;73(5):496-505. doi: 10.1016/j.jinf.2016.06.011. Epub 2016 Jul 7.


Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.

Yamaguchi M, Kurokawa T, Ishiyama K, Aoki G, Ueda M, Matano S, Takami A, Yamazaki H, Sawazaki A, Yamauchi H, Yoshida T, Nakao S.

Ann Hematol. 2011 Oct;90(10):1209-17. doi: 10.1007/s00277-011-1277-1. Epub 2011 Jun 22.


Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

Mehta PA, Vinks AA, Filipovich A, Bleesing J, Jodele S, Jordan MB, Marsh R, Tarin R, Edwards S, Fearing D, Lawrence J, Davies SM.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1458-62. doi: 10.1016/j.bbmt.2010.05.002. Epub 2010 Jun 20. Erratum in: Biol Blood Marrow Transplant. 2011 Mar;17(3):441.


[Micafungin in invasive candidiasis among oncohematological patients].

Jarque I, Angel Sanz M.

Rev Iberoam Micol. 2009 Mar 31;26(1):75-7. doi: 10.1016/S1130-1406(09)70013-0. Epub 2009 May 7. Review. Spanish.


[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].

Salavert M, Jarque I.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:43-9. doi: 10.1016/S0213-005X(11)70009-X. Review. Spanish.


Supplemental Content

Support Center